Severity and 90-day survival of SARS-CoV-2 infection among patients with haematological disorders

References

• Arentz M, Yim E, Klaff L, et al. Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington state. JAMA. 2020;323(16):1612.
   PubMed Web of Science ®Google Scholar
• Dai M, Liu D, Liu M, et al. Patients with cancer appear more vulnerable to SARS-COV-2: a multi-center study during the COVID-19 outbreak. Cancer Discov. 2020;10(6):783–791.
   PubMed Web of Science ®Google Scholar
• Miyashita H, Mikami T, Chopra N, et al. Do patients with cancer have a poorer prognosis of COVID-19? An experience in New York City. Ann Oncol. 2020;31(8):1088–1089.
   PubMed Web of Science ®Google Scholar
• Onder G, Rezza G, Brusaferro S. Case-Fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. 2020;323(18):1775–1776.
   PubMed Web of Science ®Google Scholar
• Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72314 cases from the chinese center for disease control and prevention. JAMA. 2020;323(13):1239.
   PubMed Web of Science ®Google Scholar
• Jensen H, Frederiksen H. Balance on slack line; diagnostic intensity and patient safety during the SARS-CoV-2 pandemic. Acta Oncol. 2021;60(1):1–3.
   PubMed Web of Science ®Google Scholar
• Zhang H, Han H, He T, et al. Clinical characteristics and outcomes of COVID-19-Infected cancer patients: a systematic review and Meta-Analysis. J Natl Cancer Inst. 2020;113(4):371–380.
   Google Scholar
• ElGohary GM, Hashmi S, Styczynski J, et al. The risk and prognosis of COVID-19 infection in cancer patients: a systematic review and meta-analysis. Hematol Oncol Stem Cell Ther. 2020. DOI:https://doi.org/10.1016/j.hemonc.2020.07.005
   PubMedGoogle Scholar
• Vijenthira A, Gong IY, Fox TA, et al. Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and Meta-analysis of 3377 patients. Blood. 2020;136(25):2881–2892.
   PubMed Web of Science ®Google Scholar
• Reilev M, Kristensen KB, Pottegard A, et al. Characteristics and predictors of hospitalization and death in the first 11 122 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: a nationwide cohort. Int J Epidemiol. 2020;49(5):1468–1481.
   PubMed Web of Science ®Google Scholar
• Ehmsen S, Jakobsen LH, Lendorf ME, et al. Severity and 1-month outcome of SARS-CoV-2 infection in patients with solid cancers: a danish nationwide cohort study. Acta Oncol. 2021;60(7):859–865.
   PubMed Web of Science ®Google Scholar
• Passamonti F, Cattaneo C, Arcaini L, et al.; ITA-HEMA-COV Investigators. Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study. Lancet Haematol. 2020;7(10):e737–e745.
   PubMed Web of Science ®Google Scholar
• Lee LYW, Cazier JB, Starkey T, et al. COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study. Lancet Oncol. 2020;21(10):1309–1316.
   PubMed Web of Science ®Google Scholar
• Monin L, Laing AG, Munoz-Ruiz M, et al. Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study. Lancet Oncol. 2021;22:(6)765–778.
   PubMed Web of Science ®Google Scholar
• Cattaneo C, Daffini R, Pagani C, et al. Clinical characteristics and risk factors for mortality in hematologic patients affected by COVID-19. Cancer. 2020;126(23):5069–5076.
   PubMed Web of Science ®Google Scholar
• Chari A, Samur MK, Martinez-Lopez J, et al. Clinical features associated with COVID-19 outcome in MM: First results from international myeloma society dataset. Blood. 2020;136(26):3033–3040.
   PubMed Web of Science ®Google Scholar
• Hollein A, Bojko P, Schulz S, et al. Characteristics and outcomes of patients with cancer and COVID-19: results from a cohort study. Acta Oncol. 2021;60(1):24–27.
   PubMed Web of Science ®Google Scholar
• Muntanola A, Villacampa G, Hernandez-Rivas JA, et al.; of the GELLC (Grupo Español de Leucemia Linfática Crónica). Clinical characteristics and outcome of SARS-CoV-2 infection in admitted patients with chronic lymphocytic leukemia from a single european country. Exp Hematol Oncol. 2020;9(1):37.
   PubMed Web of Science ®Google Scholar
• Salisbury RA, Curto-Garcia N, O'Sullivan J, et al. Results of a national UK physician reported survey of COVID-19 infection in patients with a myeloproliferative neoplasm. Leukemia. 2021;35(8):2424–2430.
   PubMed Web of Science ®Google Scholar
• Helleberg M, Niemann CU, Moestrup KS, et al. Response to aviv et al. J Infect Dis. 2021;224(3):559–561.
   PubMed Web of Science ®Google Scholar
• Lund LC, Hallas J, Nielsen H, et al. Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission: a danish population-based cohort study. Lancet Infect Dis. 2021;21(10);1373–1382.
   PubMed Web of Science ®Google Scholar
• Glenthoj A, Jakobsen LH, Sengelov H, et al. SARS-CoV-2 infection among patients with haematological disorders: Severity and one-month outcome in 66 danish patients in a nationwide cohort study. Eur J Haematol. 2020;106(1):72–81.
   PubMed Web of Science ®Google Scholar
• Miller MD, Paradis CF, Houck PR, et al. Rating chronic medical illness burden in geropsychiatric practice and research: application of the cumulative illness rating Scale. Psychiatry Res. 1992;41(3):237–248.
   PubMed Web of Science ®Google Scholar
• Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel Coronavirus-Infected pneumonia in wuhan, China. JAMA. 2020;323(11):1061.
   PubMed Web of Science ®Google Scholar
• Clopper CJ, Pearson ES. The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika. 1934;26(4):404–413.
   Google Scholar
• Martín-Moro F, Marquet J, Piris M, et al. Survival study of hospitalised patients with concurrent COVID-19 and haematological malignancies. Br J Haematol. 2020;190(1):e16–e20.
   PubMed Web of Science ®Google Scholar
• Williamson EJ, Walker AJ, Bhaskaran K, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584(7821):430–436.
   PubMed Web of Science ®Google Scholar
• Wynants L, Van Calster B, Bonten MMJ, et al. Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal. BMJ. 2020;369:m1328.
   PubMed Web of Science ®Google Scholar
• Cook G, Ashcroft AJ, Pratt G, et al.; the United Kingdom Myeloma Forum. Real-world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID-19 disease) in patients with multiple myeloma receiving systemic anti-cancer therapy. Br J Haematol. 2020;190(2):e83–e86.
   PubMed Web of Science ®Google Scholar
• Kuderer NM, Choueiri TK, Shah DP, COVID-19 and Cancer Consortium, et al. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet. 2020;395(10241):1907–1918.
   PubMed Web of Science ®Google Scholar
• Karlsson LK, Jakobsen LH, Hollensberg L, et al. Clinical presentation and mortality in hospitalized patients aged 80+ years with COVID-19-a retrospective cohort study. Arch Gerontol Geriatr. 2021;94:104335.
   PubMed Web of Science ®Google Scholar
• Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513.
   PubMed Web of Science ®Google Scholar
• Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601–615.
   PubMed Web of Science ®Google Scholar
• Del Bello A, Marion O, Vellas C, et al. Anti-SARS-Cov-2 monoclonal antibodies in Solid-Organ-Transplant patients. Transplantation. 2021;105(10):e146–e147.
   PubMed Web of Science ®Google Scholar